Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
"Oral SLU-PP-332" marketed with claims of "high oral bioavailability" that contradicts Billon 2025 (PMID 41421047), which is the paper that explicitly identified the parent compound's lack of oral bioavailability as the reason SLU-PP-915 was developed
GLP-1 Medications Linked to Increased Hair Loss in New Study Heres How Much They Raise the Risk of Alopecia NEED TO KNOW A study from researchers at the University of Pennsylvania found GLP-1 medications are linked to a higher risk of hair loss, primarily non-scarring alopecia Hair loss cases remain rare, with 3 to 9 per 1,000 users annually, but may impact treatment decisions GLP-1 drugs, originally for type 2 diabetes, are now also widely used for weight management and appetite control A new study has linked the use of GLP-1s with increased hair loss
Stadman E.R
Semaglutide: Semaglutide has helped people lose an average of 15% of their body weight over a similar time period
The Precision Peptide Genetic Test available through PlexusDx maps 14 metabolic pathways and 49 peptides to identify how individual genetic variantsincluding FTO rs9939609influence weight loss response and appetite regulation
